Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchison China MediTech Ltd (HCM US)
Watchlist
40
Analysis
Health Care
•
Hong Kong
Hutchison China MediTech Ltd develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech markets its products globally.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hutchison China MediTech Ltd
•
24 Mar 2020 20:37
•
Issuer-paid
Hutchison China MediTech - From innovation to oncology commercialization
Hutchison China MediTech’s (HCM’s) investment case is focused on evolution into a global R&D and commercial-stage biopharma company with a...
Edison Investment Research
Follow
467 Views
Share
bullish
•
Hutchison China MediTech Ltd
•
23 Mar 2020 22:08
•
Issuer-paid
Hutchison China MediTech - From innovation to oncology commercialisation
Hutchison China MediTech’s (HCM’s) investment case is focused on evolution into a global R&D and commercial-stage biopharma company with a...
Edison Investment Research
Follow
474 Views
Share
bullish
•
Central Retail Corp Ltd
•
26 Jan 2020 11:42
ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Happy...
Zhen Zhou, Toh
438 Views
Share
bullish
•
Hutchison China MediTech Ltd
•
22 Jan 2020 18:02
Hutchison-China Meditech Placement: Catalysts to Expect but Keep Overhang in Mind
HCM, a leading China biotech company, filed a prospectus to sell USD 110 million of ADS. We have covered the company's fundamentals for its Hong...
Ke Yan, CFA, FRM
Follow
477 Views
Share
bullish
•
Hutchison China MediTech Ltd
•
28 Jun 2019 16:51
Hutchison-China Meditech (和黄医药) Placement: Big Discount After HK Listing Delayed
HCM, a leading China biotech company, filed a prospectus to sell 8.5 million secondary ADSs. We have covered the company's fundamentals for its...
Ke Yan, CFA, FRM
Follow
528 Views
Share
First
Previous
4
5
6
7
8
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x